Calcified Tissue International

The First International Conference on Osteoporosis in Men Siena, Italy, February 23–25, 2001

C. Gennari, E. Seeman

The Prevalence of Osteoporosis: Gender and Racial Comparison

L. Joseph Melton

Mortality, Morbidity, and Assessment of Fracture Risk in Male Osteoporosis

O. Johnell, J. Kanis, G. Gullberg

Androgens: Basic Biology and Clinical Implication

E.S. Orwoll

Estrogens and Bone Health in Men

S. Khosla, L.J. Melton, B.L. Riggs

Secondary Causes of Osteoporosis in Men

J. Compston

Skeletal Effects of Exercise in Men

M.K. Karlsson

Genetics of Male Osteoporosis

L. Gennari, M.L. Brandi

During Aging, Men Lose Less Bone Than Women Because They Gain More Periosteal Bone, Not Because They Resorb Less Endosteal Bone

E. Seeman

Histomorphometric Approach of Bone Loss in Men

P. Chavassieux, P.J. Meunier

Bone Microarchitecture and Bone Fragility in Men: DXA and Histomorphometry in Humans and in the Orchidectomized Rat Model

M. Audran, D. Chappard, E. Legrand, H. Libouban, M.F. Baslé

Diagnosis of Osteoporosis and Fracture Threshold in Men

J.A Kanis, O. Johnell, A. Oden, C. De Laet, D. Mellstrom

The Assessment of Bone Mass in Men

A. Lombardi, P.D. Ross

Use of Quantitative Ultrasound Densitometry (QUS) in Male Osteoporosis

C. Wüster, P. Hadji

Biochemical Markers of Bone Turnover in Men

P. Szulc, P.D. Delmas

Androgen Replacement in Aging Men

R.M. Francis

Alendronate for the Treatment of Osteoporosis in Men

S. Adami, R. Prizzi, F. Colapietro

Risedronate Increases Bone Density and Reduces Vertebral Fracture Risk Within One Year in Men on Corticosteroid Therapy

D.M. Reid, S. Adami, J.-P. Devogelaer, A.A. Chines

Therapy of Male Osteoporosis with Parathyroid Hormone

J.P. Bilezikian, E.S. Kurland

Treatment of Osteoporosis in Men with Fluoride Alone or in Combination with Bisphosphonates

J.D. Ringe, L.C. Rovati

Announcements